ID: ALA498632

Max Phase: Preclinical

Molecular Formula: C14H16NO3P

Molecular Weight: 277.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)C(NCc1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C14H16NO3P/c16-19(17,18)14(13-9-5-2-6-10-13)15-11-12-7-3-1-4-8-12/h1-10,14-15H,11H2,(H2,16,17,18)

Standard InChI Key:  SLMGIUOAZCYKPE-UHFFFAOYSA-N

Associated Targets(Human)

Prostatic acid phosphatase 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 277.26Molecular Weight (Monoisotopic): 277.0868AlogP: 2.65#Rotatable Bonds: 5
Polar Surface Area: 69.56Molecular Species: ACIDHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: -0.72CX Basic pKa: 5.96CX LogP: 0.91CX LogD: -0.13
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.73Np Likeness Score: -0.40

References

1. Vovk AI, Mischenko IM, Tanchuk VY, Kachkovskii GA, Sheiko SY, Kolodyazhnyi OI, Kukhar VP..  (2008)  Stereoselectivity of binding of alpha-(N-benzylamino)benzylphosphonic acids to prostatic acid phosphatase.,  18  (16): [PMID:18672366] [10.1016/j.bmcl.2008.07.021]

Source